PPT-Direct oral anticoagulant (DOAC) haemorrhage protocol

1 Contact haematologist on call document DOAC taken and last time drug ingested calculate creatinine clearance Cockcroft Gault FBC and check INRAPTTthrombin time Dabigatran Rivaroxaban. Presented by Dr Azza Serry. Learning objectives . Definition , causes &classification .. Pathophysiology & physiological response of haemorrhagic shock .. Management of haemorrhagic shock . . R2 Patcharee Seesongsom. R2 . Sirada. . Phojai. Advisor AJ . T. a. chawan. . J. iratiwanon. Scope. Overview. Introduction of NOACs. Rivaroxaban. ( . Xarelto. ). Dabigatran. ( . Pradaxa. ). Fawaz Altuwaijri. ACEM trainee. Introduction. Characteristics . of novel . anticoagulants. Laboratory Testing. Reversal in the bleeding patient. Introduction. Prevalence . atrial fibrillation. . 3.03 million in 2005. and major trauma. Dr. Tina . Biss. Consultant . Haematologist. Newcastle Hospitals NHS Foundation Trust. NTN Annual Trauma . Conference. 17. th. April 2015. Case history. 73 year old female . Anticoagulated. Lanae Fox, . PharmD. , BCPS. I have no financial disclosures to report. Objectives. Understand the relative benefits and limitations of oral anticoagulant options. Recognize strategies for optimal use of oral anticoagulants and minimize risk of bleeding with these agents. An Educational Slide Set . American Society of Hematology 2018 Guidelines . for Management of Venous Thromboembolism. Slide set authors: . E. ric. Tseng MD . MScCH. , University of Toronto. Daniel Witt PharmD, University of Utah. Clair . Huckerby. Pharmaceutical Adviser- Medicines Optimisation . Lead. Dudley CCG. Our mission. To improve the . health and wellbeing . of the . population . of . Dudley . through the . safe and effective . Sean O’Brien. ADAS Deputy Manager. Bev . Straker - Bennett Senior Specialist Anticoagulation BMS. August 2019. Service Provision. ADAS is a Consultant . led . service managed by the Pathology . Directorate.. 2018-2019. Haemorrhage . →. hypovolaemic shock . T. issue . trauma . + . hypovolaemic . shock . →. Acute . T. raumatic Coagulopathy . (ATC. ). ATC . → . Trauma-Induced . C. oagulopathy . (. TIC) . Patients with anticoagulant. (n=37). R-CHOP,. . n (%). 156 (51.0). 14 (37.8). R-CEOP, . n (%). 68 (22.2). 7 (18.9). R-CHOEP, . n (%). 47 (15.3). 2 (5.4). R-CVOP, . n (%). 11 (3.6). 10 (27.0). R-mini-CHOP, . existing clots from growing larger. Although anticoagulants are sometimes called blood thinners , they do not actually thin the blood. The job of anticoagulants is to promote the smooth flow of bloo Presented by-. Dr. Varun Mittal, PG. Dept of Maxillofacial Surgery. SRM DENTAL COLLEGE, CHENNAI, INDIA. Which all patients?. Mostly cardiac or vascular disorders:. Atrial. fibrillation. Ischemic cardiac disease. template. * . An MHP includes a multidisciplinary approach to haemorrhage control^, correction of coagulopathy and normalisation of patient physiological parameters . (insert key contact names and numbers). An MHP includes a multidisciplinary approach to haemorrhage control, correction of coagulopathy and normalisation of physiological parameters. Senior clinician determines patient requires MHP activation.